ResearchHub Logo
Currency
Display format
RSCUSD

Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment

Authors
Sylvain GarciazAlberto SantagostinoChristian Récher
Journal
American Journal of Hematology
Published
June 20, 2024
Sign in to comment
Add a comment...

No comments yet. Start the conversation!

Your contribution could help open science.

Supporters

Support the authors with ResearchCoin

Topics

DOI

10.1002/ajh.27417

License

cc-by-nc-nd
Outcomes of acute myeloid leukemia patients who responded... | ResearchHub